Latest Breaking News On - Primary focuses - Page 1 : comparemela.com

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Darren jiNaoki okamuraAdam pearsonElpiscience biopharma ltdAreas of interest astellas pharma incResearch collaborationAstellas pharma incAstellas enterLicense agreementNovel bispecific macrophageAstellas pharmaBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focuses

Elpiscience And Astellas Enter Into Research Collaboration And License Agreement For Novel Bispecific Macrophage Engager

Elpiscience And Astellas Enter Into Research Collaboration And License Agreement For Novel Bispecific Macrophage Engager
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Darren jiAdam pearsonNaoki okamuraAstellas pharma incAreas of interest astellas pharma incPrnewswire elpiscience biopharma ltdAstellas pharmaBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focusesFocus area approachBispecific macrophage engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Naoki okamuraDarren jiAdam pearsonAreas of interest astellas pharma incElpiscience biopharma ltdAstellas pharma incCorporate communicationsAstellas pharmaBusiness wireBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focusesFocus area approachBispecific macrophage engager

Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders

Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Adam pearsonNaoki okamuraPatrickc reidKeiichi masuyaPeptidream incAstellas pharma incResearch collaborationPeptidream enterLicense agreementDiscover novel targeted proteinPeptide discovery platform systemChief strategy officerProtein degradationPrimary focusesChief operating officerPress release image

Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Ta

TOKYO & KAWASAKI, Japan (BUSINESS WIRE) #proteindegrader Astellas Pharma Inc. (TOKYO: 4503, President and CEO: Naoki Okamura, “Astellas”) and PeptiDream Inc. (TOKYO: 4587, President and CEO: Patrick C. Reid, “PeptiDream”) today announced a research collaboration and license agreement to discover novel protein deg.

Keiichi masuyaNaoki okamuraAdam pearsonPatrickc reidAstellas pharma incTokyo stock exchange prime sectionPeptidream incIr public affairsCorporate communicationsAstellas pharmaPeptide discovery platform systemChief strategy officerProtein degradationPrimary focusesChief operating officerFocus area approach